IMDX
Insight Molecular Diagnostics Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:41:49 AM EST
1.66USD+6.731%(+0.11)11,801
IMDX Financials
In Q3 FY 2026 (ended ), Insight Molecular Diagnostics Inc. Common Stock (IMDX) reported revenue of $559K, net income of −$3.58M, operating cash flow of −$6.43M, and assets of $21.74M (filed ).
Loading financial flows…